Considering that the frequency of peritoneal metastasis is less in G-CSF-producing gastric ASC than in pure gastric adenocarcinoma [11], the prognosis is expected to improve with aggressive resection as long as all disease can be removed. The gene discussed is CSF3; the disease is gastric adenocarcinoma.